Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 19, 2026 | CMS / Medicare | MolDX: Molecular Testing for Solid Organ Allograft Rejection | Metadata changed |
| May 19, 2026 | CMS / Medicare | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Inpatient Hospital Stays for Treatment of Alcoholism | Metadata changed |
| May 19, 2026 | CMS / Medicare | Chimeric Antigen Receptor (CAR) T-cell Therapy | Metadata changed |
| May 19, 2026 | CMS / Medicare | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Autologous Cellular Immunotherapy Treatment | Metadata changed |
| May 19, 2026 | CMS / Medicare | Erythropoiesis Stimulating Agents (ESAs) in Cancer and Related Neoplastic Conditions | Metadata changed |
| May 19, 2026 | CMS / Medicare | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | B-type Natriuretic Peptide (BNP) Testing | Metadata changed |
| May 19, 2026 | CMS / Medicare | Blood Brain Barrier Osmotic Disruption for Treatment of Brain Tumors | Metadata changed |
| May 19, 2026 | CMS / Medicare | Botulinum Toxins | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| May 19, 2026 | CMS / Medicare | Aprepitant for Chemotherapy-Induced Emesis | Metadata changed |
| May 19, 2026 | CMS / Medicare | Anti-Cancer Chemotherapy for Colorectal Cancer - RETIRED | Metadata changed |
| May 19, 2026 | CMS / Medicare | Intervertebral Disc Repair | Metadata changed |
| May 19, 2026 | CMS / Medicare | Total Shoulder Arthroplasty | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Metadata changed |
| May 19, 2026 | CMS / Medicare | Intervertebral Disc Repair | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Metadata changed |
| May 19, 2026 | CMS / Medicare | Knee Orthoses | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Non-invasive Extracranial Arterial Studies | Metadata changed |
| May 19, 2026 | CMS / Medicare | Botulinum Toxin Injections | Metadata changed |
| May 19, 2026 | CMS / Medicare | Nonselective (Random) Transfusions and Living Related Donor Specific Transfusions (DST) in Kidney Transplantation | Metadata changed |
| May 19, 2026 | CMS / Medicare | Apheresis (Therapeutic Pheresis) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Skin Substitutes Grafts/Cellular Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers | Metadata changed |
| May 19, 2026 | CMS / Medicare | Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT )/Coronary Plaque Analysis (AI-CPA) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Cytotoxic Food Tests | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Skin Substitutes Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers | Metadata changed |
| May 19, 2026 | CMS / Medicare | Botulinum Toxin Injections | Metadata changed |
| May 19, 2026 | CMS / Medicare | Challenge Ingestion Food Testing | Metadata changed |
| May 19, 2026 | CMS / Medicare | Outpatient Psychotherapy | Metadata changed |
| May 19, 2026 | CMS / Medicare | Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Botulinum Toxin Injections | Metadata changed |
| May 19, 2026 | CMS / Medicare | Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) | Metadata changed |